A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to compare efficacy of a single dose of lumiracoxib 400 mg given pre-emptively versus post-operatively, in reducing pain associated with ambulatory arthroscopic knee surgery

Trial Profile

A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to compare efficacy of a single dose of lumiracoxib 400 mg given pre-emptively versus post-operatively, in reducing pain associated with ambulatory arthroscopic knee surgery

Completed
Phase of Trial: Phase III

Latest Information Update: 02 Jun 2011

At a glance

  • Drugs Lumiracoxib (Primary)
  • Indications Musculoskeletal pain
  • Focus Therapeutic Use
  • Sponsors Novartis
  • Most Recent Events

    • 12 Dec 2007 Status changed from in progress to completed.
    • 10 Jan 2007 Status change
    • 29 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top